Page 111 - 南京医科大学学报自然科学版
P. 111

第43卷第1期            马廷政,汪徐春,孙玉洁. 肿瘤坏死因子受体超家族成员TNFRSF19的研究进展[J].
                2023年1月                     南京医科大学学报(自然科学版),2023,43(01):100-106                         ·105 ·


               [19] HASHIMOTO T,SCHLESSINGER D,CUI C Y. Troy           gastric carcinogenesis demonstrates an inverse trend[J].
                     binding to lymphotoxin⁃alpha activates NF kappa B medi⁃  Iran Biomed J,2019,23(2):107-120
                     ated transcription[J]. Cell Cycle,2008,7(1):106-111  [32] HU Z,WU C,SHI Y,et al. A genome⁃wide association
               [20] LOFTUS J C,DHRUV H,TUNCALI S,et al. TROY(TN⁃       study identifies two new lung cancer susceptibility loci at
                    FRSF19) promotes glioblastoma survival signaling and  13q12.12 and 22q12.2 in Han Chinese[J]. Nat Genet,
                    therapeutic resistance[J]. Mol Cancer Res,2013,11(8):  2011,43(8):792-796
                    865-874                                      [33] GUO L,GAO R,GAN J,et al. Downregulation of TN⁃
               [21] LIU X,BAO Y,MENG W,et al. TROY interacts with      FRSF19 and RAB43 by a novel miRNA,miR⁃HCC3,pro⁃
                    RKIP to promote glioma development[J]. Oncogene,   motes proliferation and epithelial⁃mesenchymal transition
                    2019,38(9):1544-1559                               in hepatocellular carcinoma cells[J]. Biochem Biophys
               [22] DING Z,ROOS A,KLOSS J,et al. A novel signaling com⁃  Res Commun,2020,525(2):425-432
                    plex between TROY and EGFR mediates glioblastoma  [34] PARK J B,YIU G,KANEKO S,et al. A TNF receptor
                    cell invasion[J]. Mol Cancer Res,2018,16(2):322-332  family member,TROY,is a coreceptor with Nogo recep⁃
               [23] BEI J X,LI Y,JIA W H,et al. A genome⁃wide association  tor in mediating the inhibitory activity of myelin inhibitors
                    study of nasopharyngeal carcinoma identifies three new  [J]. Neuron,2005,45(3):345-351
                    susceptibility loci[J]. Nat Genet,2010,42(7):599-603  [35] SHAO Z,BROWNING J L,LEE X,et al. TAJ/TROY,an
               [24] BEI J X,SU W H,NG C C,et al. A GWAS meta⁃analysis  orphan TNF receptor family member,binds Nogo⁃66 re⁃
                    and replication study identifies a novel locus within  ceptor 1 and regulates axonal regeneration[J]. Neuron,
                    CLPTM1L/TERT associated with nasopharyngeal carcino⁃  2005,45(3):353-359
                    ma in individuals of Chinese ancestry[J]. Cancer Epide⁃  [36] LU Y,LIU X,ZHOU J,et al. TROY interacts with Rho
                    miol Biomarkers Prev,2016,25(1):188-192            guanine nucleotide dissociation inhibitor α(RhoGDIα)
               [25] LIU Z,GOLDSTEIN A M,HSU W L,et al. Evaluation of   to mediate Nogo⁃induced inhibition of neurite outgrowth
                    rare and common variants from suspected familial or spo⁃  [J]. J Biol Chem,2013,288(47):34276-34286
                    radic nasopharyngeal carcinoma (NPC) susceptibility  [37] LIU G,NI J,MAO L,et al. Expression of Nogo receptor 1
                    genes in sporadic NPC[J]. Cancer Epidemiol Biomarkers  in microglia during development and following traumatic
                    Prev,2019,28(10):1682-1686                         brain injury[J]. Brain Res,2015,1627:41-51
               [26] CHENG A,ZHAO S,FITZGERALD L M,et al. A four⁃  [38] YU S X,LI S,SHU H F,et al. Expression of the nogo⁃a
                    gene transcript score to predict metastatic⁃lethal progres⁃  system in cortical lesions of pediatric patients with tuber⁃
                    sion in men treated for localized prostate cancer:develop⁃  ous sclerosis complex and focal cortical dysplasia type IIb
                    ment and validation studies[J]. Prostate,2019,79(14):  [J]. J Neuropathol Exp Neurol,2012,71(7):665-677
                    1589-1596                                    [39] WILLS Z P,MANDEL⁃BREHM C,MARDINLY A R,et
               [27] SPANJAARD R A,WHREN K M,GRAVES C,et al. Tu⁃        al. The nogo receptor family restricts synapse number in
                    mor necrosis factor receptor superfamily member TROY  the developing hippocampus[J]. Neuron,2012,73(3):
                    is a novel melanoma biomarker and potential therapeutic  466-481
                    target[J]. Int J Cancer,2007,120(6):1304-1310  [40] SUN L,LIU S,SUN Q,et al. Inhibition of TROY promotes
               [28] C OKIC V P,MOSSUZ P,HAN J,et al. Microarray and    OPC differentiation and increases therapeutic efficacy of
                     proteomic analyses of myeloproliferative neoplasms with  OPC graft for spinal cord injury[J]. Stem Cells Dev,
                     a highlight on the mTOR signaling pathway[J]. PLoS  2014,23(17):2104-2118
                     One,2015,10(8):e0135463                     [41] TAM S J,RICHMOND D L,KAMINKER J S,et al. Death
               [29] SCHÖN S,FLIERMAN I,OFNER A,et al. β⁃catenin reg⁃   receptors DR6 and TROY regulate brain vascular develop⁃
                    ulates NF⁃κB activity via TNFRSF19 in colorectal cancer  ment[J]. Dev Cell,2012,22(2):403-417
                    cells[J]. Int J Cancer,2014,135(8):1800-1811  [42] WANG Y,LI X,WANG L,et al. An alternative form of
               [30] FRANZISKA W,CHRISTINE B,SANDRA K,et al. Troy       paraptosis⁃like cell death,triggered by TAJ/TROY and en⁃
                    is expressed in human stomach mucosa and a novel puta⁃  hanced by PDCD5 overexpression[J]. J Cell Sci,2004,
                    tive prognostic marker of intestinal type gastric cancer[J].  117(pt 8):1525-1532
                    Oncotarget,2017,8(31):50557-50569            [43] 陈   灿,刘岑鸟,蒋永新. TNFRSF19 基因研究性进展
               [31] SABERI S,PIRYAEI A,MIRABZADEH E,et al.Immuno⁃     [J]. 现代肿瘤医学,2012,20(10):2200-2203
                    histochemical analysis of LGR5 and TROY expression in  [44] BASAK O,KRIEGER T G,MURARO M J,et al. Troy+
   106   107   108   109   110   111   112   113   114   115   116